Alternative names:C antibody,Capsid protein antibody,Core and e antigen antibody,Core antigen antibody,Core antigen antibody,Core protein antibody,HBc antibody,HBcAg antibody,HBVgp4 antibody,Hepatitis B Virus core antigen antibody,p21.5 antibody,precore/core protein antibody
Speficity: Mouse monoclonal IgG,affinity purified by Protein A
Reacts with : Hepatitis B virus
Clone number:14E11
Myeloma:Sp2/0
Isotype:IgG2b
Immunogen: Purified Denatured Hepatitis B Core Antigen
Target: Hepatitis B Virus Core Antigen (HBcAg) is part of the infectious virion containing an inner"core particle" enclosing the viral genome. The icosahedral core particle contains 180 or 240copies of the core protein. HBcAg is one of the three major clinical antigens of hepatitis B virus but disappears early in the course of infection. The hepatitis B virus core antigen (HBcAg) is a highly immunogenic subviral particle and functions as both a T-cell-dependent and a T-cell-independent antigen. Therefore, HBcAg may be a promising candidate target for therapeutic vaccine control of chronic HBV infection.
Capsid protein: Virion. Host cytoplasm, hepatocyte nucleus.
Application: ELISA: Use at an assay dependent dilution.
IHC-FoFr: 1/100 ,IHC-Fr: 1/100,Elisa:1:500-1000
ICC/IF: Use at an assay dependent dilution.
IP: Use at an assay dependent dilution.
IHC-P: 1/100.WB: 1/1000.
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
上海安研,供應(yīng)HBcAg抗體相對應(yīng)的抗原
HBcAg抗原
HBcAg antigen
相關(guān)產(chǎn)品
免責(zé)聲明
- 凡本網(wǎng)注明“來源:化工儀器網(wǎng)”的所有作品,均為浙江興旺寶明通網(wǎng)絡(luò)有限公司-化工儀器網(wǎng)合法擁有版權(quán)或有權(quán)使用的作品,未經(jīng)本網(wǎng)授權(quán)不得轉(zhuǎn)載、摘編或利用其它方式使用上述作品。已經(jīng)本網(wǎng)授權(quán)使用作品的,應(yīng)在授權(quán)范圍內(nèi)使用,并注明“來源:化工儀器網(wǎng)”。違反上述聲明者,本網(wǎng)將追究其相關(guān)法律責(zé)任。
- 本網(wǎng)轉(zhuǎn)載并注明自其他來源(非化工儀器網(wǎng))的作品,目的在于傳遞更多信息,并不代表本網(wǎng)贊同其觀點和對其真實性負責(zé),不承擔(dān)此類作品侵權(quán)行為的直接責(zé)任及連帶責(zé)任。其他媒體、網(wǎng)站或個人從本網(wǎng)轉(zhuǎn)載時,必須保留本網(wǎng)注明的作品第一來源,并自負版權(quán)等法律責(zé)任。
- 如涉及作品內(nèi)容、版權(quán)等問題,請在作品發(fā)表之日起一周內(nèi)與本網(wǎng)聯(lián)系,否則視為放棄相關(guān)權(quán)利。